Cargando…
Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer
Prostate cancer is one of the most common cancers in men worldwide, and primary prostate cancer is typically treated with surgery, radiation, androgen deprivation, or a combination of these therapeutic modalities. Despite technical advances, approximately 30% of men will experience biochemical recur...
Autores principales: | Galgano, Samuel J., Valentin, Roberto, McConathy, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178324/ https://www.ncbi.nlm.nih.gov/pubmed/30363475 http://dx.doi.org/10.21037/tau.2018.06.09 |
Ejemplares similares
-
Lymph node imaging in initial staging of prostate cancer: An overview and update
por: Zarzour, Jessica G, et al.
Publicado: (2017) -
Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method
por: Fang, Yu-Hua Dean, et al.
Publicado: (2022) -
Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
por: Ikotun, Oluwatayo F., et al.
Publicado: (2013) -
Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
por: Galgano, Samuel J., et al.
Publicado: (2022) -
Feasibility of Dose Escalating [(18)F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
por: McDonald, Andrew M., et al.
Publicado: (2019)